Determining hirsutism diagnosis criteria in Polish women with PCOS
Official title: Diagnostics of Clinical Hyperandrogenism Using the Modified Ferriman-Gallwey Scale and the Ludwig Scale in Women With Normogonadotropic Anovulation
Run by Jagiellonian University · NCT06530498 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is trying to find the best way to diagnose excessive hair growth in Polish women with PCOS by using a specific scale and looking at how it relates to hair loss.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Jagiellonian University Academic / other |
| Locations | 1 site (Krakow) |
| Trial ID | NCT06530498 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18-45 with a diagnosis of PCOS and oligoovulation.
✕Probably not a fit
Patients outside the age range of 18-45 or without a diagnosis of PCOS may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to establish the optimal cut-off value for diagnosing hirsutism using the modified Ferriman-Gallwey (mFG) scale among Polish women diagnosed with polycystic ovary syndrome (PCOS). It will also assess the correlation between the severity of hirsutism and androgenetic alopecia using the Ludwig scale. Participants will undergo visual assessments to evaluate the severity of both conditions, focusing on women aged 18-45 with oligoovulation. The study is conducted at the University Hospital in Krakow.
Why it matters
Potential benefit: If successful, this study could provide a standardized diagnostic criterion for hirsutism, improving treatment approaches for women with PCOS.
How similar studies have gone: While similar studies have explored hirsutism and androgenetic alopecia, this specific approach to establish cut-off values in the Polish population is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * oligoovulation, i.e. menstrual cycles every \<21 days or \>35 days * age 18-45 years * diagnosis of PCOS. Exclusion Criteria: * none
Where it's running
-
Jagiellonian University Medical College
Krakow, Poland Recruiting
Study contacts
- Study coordinator: Iwona Gawron, MD, PhD
- Email: iwona.gawron@uj.edu.pl
- Phone: +48 124248570
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PMOS and Sleep Apnea: A Pilot Look at Mitochondrial Function
In women with PMOS, this pilot study tests whether sleep apnea treatment with CPAP improves mitochondrial function in leg muscle tissue.
-
PCOS and Brain Health
This study tests how PCOS may affect brain blood flow, brain structure, and thinking skills in reproductive-age people with and without PCOS.
-
Adding cabergoline to letrozole for ovulation in PCOS
This study will see if adding cabergoline to letrozole helps women with PCOS ovulate more often.
-
Extended vs standard letrozole for ovulation induction in women with PCOS.
This test will see if taking letrozole for 10 days helps women with PCOS ovulate and get pregnant better than the usual 5-day course.
-
Investigating cardiovascular markers in women with PCOS during glucose testing
This study is testing how glucose testing affects heart health markers in women with PCOS and whether different treatments can improve those markers over six months.
-
PIMS versus PGT-A for embryo selection in women with PCOS
This test will see if selecting embryos with Pre-implantation Methylation Screening (PIMS) instead of PGT-A plus standard morphology leads to higher cumulative live birth rates and lower early pregnancy loss for women with PCOS undergoing IVF/ICSI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.